Despite evidence of adiponectin as a cardiovascular risk marker supported by early reports of a strong inverse association with incident coronary heart disease (CHD) in healthy middle-aged males[8], the inverse relationship between adiponectin and CHD was comparatively moderate in other populations[9]. Here, ADIPOQ is linked to coronary artery disorder.